February 10, 2026 - 21:39

Two recently appointed voting members of the Federal Reserve’s policy committee expressed a shared preference on Tuesday for maintaining the current benchmark interest rate, citing ongoing inflation concerns. Their comments underscore the cautious stance prevailing among officials as they navigate the final stage of the inflation fight.
The policymakers indicated that while progress has been made in cooling price increases, the data remains insufficiently convincing to warrant a reduction in borrowing costs. They emphasized the need for greater confidence that inflation is sustainably moving toward the central bank's two percent target before considering any policy easing. High interest rates are a tool used to temper economic demand and, consequently, inflation.
Their stance aligns with recent broader Fed communications, which have signaled a patient approach. The officials noted that the labor market, while strong, shows signs of gradual cooling, and the economy continues to expand at a solid pace. This combination allows the committee time to assess incoming information without the immediate pressure to adjust rates. The consensus view is that the current policy level is restrictive enough to continue guiding inflation downward, provided it is given more time to take full effect. The next policy meeting will be closely watched for further signals on the timing of any potential shift.
March 27, 2026 - 21:27
Social Media Giants Face Market Pressure Following Legal SetbackShares of major social media companies extended their losses on Friday, as investors continued to digest the financial and regulatory implications of a recent legal defeat. The sell-off reflects...
March 27, 2026 - 00:26
NDSU College of Business launches Center for Banking and FinanceA new hub dedicated to the financial sector has officially opened its doors, aiming to bridge the gap between academic theory and real-world practice. The recently launched Center for Banking and...
March 26, 2026 - 05:08
Precigen Reports Full Year 2025 Financial Results and Business UpdatesPrecigen, Inc. has officially transitioned into a commercial-stage biotechnology company, marking a transformative year in 2025. This shift follows the landmark US approval of PAPZIMEOS™...
March 25, 2026 - 01:12
Tech stocks today: Anthropic announces new Claude capability, Nvidia's Jensen Huang says AGI era is hereThe technology sector is buzzing with two major announcements that underscore the rapid acceleration of artificial intelligence development. AI startup Anthropic has unveiled a significant new...